Invesaro

Stocks Comparison

CONMED vs InMode: revenue, profit, margins and growth compared

CONMED brought in $1.4B of revenue in fiscal 2025, InMode $370.5M in fiscal 2025. Revenue changed by +5.2% at CONMED and -6.2% at InMode on the year before, so CONMED grew faster. CONMED kept 3.4% of its revenue as net profit, InMode 25.3%. Free cash flow was $150.9M at CONMED and $84.3M at InMode.

Side by side, latest fiscal year

CNMDINMD
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$1.4B$370.5M
Revenue growth+5.2%-6.2%
Net income$47.1M$93.8M
Net margin3.4%25.3%
Free cash flow$150.9M$84.3M
Free cash flow margin11.0%22.7%
Earnings per share (diluted)$1.51$1.43
Cash$40.8M$302.5M
Debt$834.9Mn/a
Price to earnings30.1n/a
Market value$1.4B$903.5M
Dividend yield1.32%n/a
Rank by revenue in sector#131 of 523 · Health care#211 of 523 · Health care

Over the years

Revenue
CNMD FY2018: $859.6MCNMD FY2019: $955.1MCNMD FY2020: $862.5MCNMD FY2021: $1BCNMD FY2022: $1BCNMD FY2023: $1.2BCNMD FY2024: $1.3BCNMD FY2025: $1.4BINMD FY2019: $100.2MINMD FY2019: $156.4MINMD FY2020: $206.1MINMD FY2021: $357.6MINMD FY2022: $454.3MINMD FY2023: $492MINMD FY2024: $394.8MINMD FY2025: $370.5MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $1.4BINMD $370.5M
Net income
CNMD FY2018: $40.9MCNMD FY2019: $28.6MCNMD FY2020: $9.5MCNMD FY2021: $62.5MCNMD FY2022: -$80.6MCNMD FY2023: $64.5MCNMD FY2024: $132.4MCNMD FY2025: $47.1MINMD FY2019: $22.4MINMD FY2019: $61.1MINMD FY2020: $75MINMD FY2021: $165MINMD FY2022: $161.5MINMD FY2023: $197.9MINMD FY2024: $181.3MINMD FY2025: $93.8MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $47.1MINMD $93.8M
Net margin
CNMD FY2018: 4.8%CNMD FY2019: 3.0%CNMD FY2020: 1.1%CNMD FY2021: 6.2%CNMD FY2022: -7.7%CNMD FY2023: 5.2%CNMD FY2024: 10.1%CNMD FY2025: 3.4%INMD FY2019: 22.3%INMD FY2019: 39.1%INMD FY2020: 36.4%INMD FY2021: 46.1%INMD FY2022: 35.6%INMD FY2023: 40.2%INMD FY2024: 45.9%INMD FY2025: 25.3%FY18FY19FY20FY21FY22FY23FY24FY25
CNMD 3.4%INMD 25.3%
Revenue growth
CNMD FY2019: +11.1%CNMD FY2020: -9.7%CNMD FY2021: +17.2%CNMD FY2022: +3.4%CNMD FY2023: +19.1%CNMD FY2024: +5.0%CNMD FY2025: +5.2%INMD FY2019: +56.1%INMD FY2020: +31.8%INMD FY2021: +73.5%INMD FY2022: +27.0%INMD FY2023: +8.3%INMD FY2024: -19.8%INMD FY2025: -6.2%FY19FY20FY21FY22FY23FY24FY25
CNMD +5.2%INMD -6.2%
Free cash flow
CNMD FY2018: $58.2MCNMD FY2019: $75.1MCNMD FY2020: $51.5MCNMD FY2021: $96.9MCNMD FY2022: $11.6MCNMD FY2023: $106.3MCNMD FY2024: $153.9MCNMD FY2025: $150.9MINMD FY2019: $36.5MINMD FY2019: $61.5MINMD FY2020: $78.8MINMD FY2021: $173.9MINMD FY2022: $180MINMD FY2023: $176.1MINMD FY2024: $132MINMD FY2025: $84.3MFY18FY19FY20FY21FY22FY23FY24FY25
CNMD $150.9MINMD $84.3M

Fiscal years as each company reports them; the two may end in different months.

Questions about CONMED and InMode

Which is bigger by revenue, CONMED or InMode?

CONMED is bigger by revenue: $1.4B in fiscal 2025, against $370.5M for InMode in fiscal 2025.

Which keeps more of its revenue as profit, CONMED or InMode?

CONMED had a net margin of 3.4% in fiscal 2025; InMode had 25.3% in fiscal 2025.

Which grew revenue faster, CONMED or InMode?

In their latest fiscal years revenue changed by +5.2% at CONMED and -6.2% at InMode.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies